2026-03-30 MAPS

2026 First Quarter — Legislative Wrap Up

Policy

2026 will likely be an important year for psychedelic policy reform, with over a dozen states considering legislation and/or voter initiatives ranging from the creation of study commissions to the decriminalization of certain psychedelic substances and the development of regulated access programs. Collectively, these proposals signal growing state-level interest in evaluating the therapeutic potential of… Continue reading 2026 First Quarter — Legislative Wrap Up

External link. We are not responsible for the content.

Read more ↗

More From MAPS

2026-08-10 MAPS

MAPS Responds to Report of Progress for MDMA-assisted therapy for PTSD with FDA

August 10, 2026 — The non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) today responded to an A...

2026-07-09 MAPS

Protected: 2026 Second Quarter — Policy & Advocacy Wrap Up

There is no excerpt because this is a protected post.

2026-06-30 MAPS

Protected: MAPS Publishes Ibogaine Investigator’s Brochure as a Free, Open-Access Resource

There is no excerpt because this is a protected post.

Latest News

2026-08-12 DoubleBlind Magazine

The Toads Didn’t Consent to Being Milked, Sorry

Chasing "enlightenment" at the expense of desert toads is not the flex you think it is. [...] Read More... The post T...

2026-08-11 Microdose (industry)

Psychedelic Medicine Is Having an Identity Crisis — And That’s a Good Thing

For most of the last decade, the story of psychedelic medicine was a story about the trip itself. Guided sessions. Ey...

2026-08-11 Microdose (industry)

Enveric Biosciences Adds Another Data Point to Its Case That EB-003 Won’t Get You High

Enveric Biosciences is trying to answer one of the trickiest questions in the psychedelic drug space: can you get the...

Research
2026-08-11 Psychedelics Today

Weekly Psychedelic Policy Briefing – August 9, 2026

Jack Gorsline, investigative journalist, covers four federal developments this week. The Department of Veterans Affai...

2026-08-10 The Microdose (Berkeley)

Why don’t some people respond to psychedelics? 5 Questions for psychologist Rachel Ham

Ham discusses doing interviews with clinical trial participants who didn’t experience substantial benefits.

2026-08-10 Psychedelics Today

Ibogaine’s Moment Has Arrived. Are We Ready to Meet It?

MAPS co-executive director Ismail Lourido Ali on what the April 2026 executive order, the Texas and Colorado funding ...